Which hedge funds own ELDN? ELEDON PHARMACEUTICALS INC, Q2 2026 13F holders
4 of the hedge funds tracked by WhaleCreep disclosed a position in ELDN (ELEDON PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $6.7m in total. The largest holder by portfolio weight is Brevan Howard Capital Management at 0.0% of its book. 2 managers opened a new position this quarter: Millennium Management, Citadel Advisors.
4tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold ELDN? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.2m | 304,707 | 33% | added |
| Millennium Management | Q2 2026 | 0.0% | $3.9m | 979,712 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $791.5k | 200,900 | 717% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $850.9k | 215,973 | – | new |
How has hedge fund ownership of ELDN changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $6.7m |
| Q1 2026 | 2 | $755.7k |
| Q4 2025 | 1 | $267.3k |
| Q3 2025 | 3 | $12.2m |
| Q2 2025 | 3 | $14.7m |
| Q1 2025 | 3 | $18.2m |
| Q4 2024 | 4 | $26.7m |
| Q3 2024 | 2 | $2.4m |
| Q2 2024 | 2 | $2.1m |
| Q1 2024 | 2 | $1.5m |
| Q4 2023 | 2 | $1.4m |
| Q3 2023 | 2 | $912.5k |
| Q2 2023 | 2 | $790.8k |
| Q1 2023 | 2 | $1.3m |
| Q4 2022 | 2 | $1.2m |
| Q3 2022 | 3 | $2.5m |
Counts every tracked manager that disclosed ELDN in that quarter's filing, including managers that have since stopped filing.